Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Treatment
Findings from the United Kingdom, Japan and United States describe new data in cancer treatment research
May 10th, 2006
Cancer treatment research advances have been reported from the United Kingdom, Japan and United States. Study 1: Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumor immunity. According to a study from England, "Gene-directed enzyme-prodrug therapy (GDEPT) using nitroreductase (NTR), with efficient adenoviral delivery, and CB1954 (CB), is an effective means of directly killing tumors. However, an immune-mediated bystander effect remains an important product of GDEPT since it is often critical to the elimination of untransduced tumor cells both locally and at distal...
Source: Vaccine Weekly (2006-05-10)
|
